LEGN logo

Legend Biotech Corporation (LEGN) Cash From Operations

Annual CFO:

-$141.35M+$243.11M(+63.23%)
December 31, 2024

Summary

  • As of today, LEGN annual cash from operations is -$141.35 million, with the most recent change of +$243.11 million (+63.23%) on December 31, 2024.
  • During the last 3 years, LEGN annual cash from operations has risen by +$56.05 million (+28.39%).
  • LEGN annual cash from operations is now -145.94% below its all-time high of $307.68 million, reached on December 31, 2018.

Performance

LEGN Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNcash flow metrics

Quarterly CFO:

$28.91M+$42.24M(+316.93%)
September 30, 2025

Summary

  • As of today, LEGN quarterly cash from operations is $28.91 million, with the most recent change of +$42.24 million (+316.93%) on September 30, 2025.
  • Over the past year, LEGN quarterly cash from operations has increased by +$103.97 million (+138.53%).
  • LEGN quarterly cash from operations is now at all-time high.

Performance

LEGN Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNcash flow metrics

TTM CFO:

-$170.25M+$103.97M(+37.91%)
September 30, 2025

Summary

  • As of today, LEGN TTM cash from operations is -$170.25 million, with the most recent change of +$103.97 million (+37.91%) on September 30, 2025.
  • Over the past year, LEGN TTM cash from operations has dropped by -$17.75 million (-11.64%).
  • LEGN TTM cash from operations is now -3897.53% below its all-time high of -$4.26 million, reached on March 31, 2019.

Performance

LEGN TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

LEGN Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+63.2%+138.5%-11.6%
3Y3 Years+28.4%--
5Y5 Years-70.2%+144.9%+25.0%

LEGN Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+63.2%at high+120.5%-33.6%+55.7%
5Y5-Year-70.2%+63.2%at high+120.5%-33.6%+55.7%
All-TimeAll-Time-145.9%+63.2%at high+120.5%-3897.5%+55.7%

LEGN Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
$28.91M(+316.9%)
-$170.25M(+37.9%)
Jun 2025
-
-$13.33M(+87.2%)
-$274.22M(-4.9%)
Mar 2025
-
-$103.75M(-26.4%)
-$261.29M(-84.8%)
Dec 2024
-$141.35M(+63.2%)
-$82.09M(-9.4%)
-$141.35M(+7.3%)
Sep 2024
-
-$75.05M(>-9900.0%)
-$152.50M(-12.2%)
Jun 2024
-
-$397.00K(-102.5%)
-$135.94M(+40.2%)
Mar 2024
-
$16.18M(+117.4%)
-$227.23M(+40.9%)
Dec 2023
-$384.47M(-92.2%)
-$93.24M(-59.4%)
-$384.47M(-13.1%)
Sep 2023
-
-$58.48M(+36.2%)
-$340.01M(-20.8%)
Jun 2023
-
-$91.69M(+35.0%)
-$281.53M(-48.3%)
Mar 2023
-
-$141.05M(-189.1%)
-$189.84M(-48.9%)
Dec 2022
-$200.01M(-1.3%)
-$48.78M(+38.0%)
-$127.47M(+48.9%)
Mar 2022
-
-$78.69M(-14.8%)
-$249.31M(-26.3%)
DateAnnualQuarterlyTTM
Dec 2021
-$197.41M(+11.6%)
-$68.56M(-54.4%)
-$197.41M(-6.7%)
Sep 2021
-
-$44.39M(+23.0%)
-$185.00M(+9.7%)
Jun 2021
-
-$57.67M(-115.3%)
-$204.99M(-0.4%)
Mar 2021
-
-$26.79M(+52.3%)
-$204.20M(+8.5%)
Dec 2020
-$223.21M(-168.7%)
-$56.16M(+12.8%)
-$223.21M(+1.7%)
Sep 2020
-
-$64.38M(-13.2%)
-$227.04M(-59.1%)
Jun 2020
-
-$56.88M(-24.2%)
-$142.72M(-14.5%)
Mar 2020
-
-$45.80M(+23.7%)
-$124.60M(-50.0%)
Dec 2019
-$83.06M(-127.0%)
-$59.99M(-400.7%)
-$83.06M(-259.9%)
Sep 2019
-
$19.95M(+151.5%)
-$23.08M(+46.4%)
Jun 2019
-
-$38.77M(-810.2%)
-$43.02M(-910.2%)
Mar 2019
-
-$4.26M
-$4.26M
Dec 2018
$307.68M(>+9900.0%)
-
-
Dec 2017
-$2.38M
-
-

FAQ

  • What is Legend Biotech Corporation annual cash from operations?
  • What is the all-time high annual cash from operations for Legend Biotech Corporation?
  • What is Legend Biotech Corporation annual cash from operations year-on-year change?
  • What is Legend Biotech Corporation quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Legend Biotech Corporation?
  • What is Legend Biotech Corporation quarterly cash from operations year-on-year change?
  • What is Legend Biotech Corporation TTM cash from operations?
  • What is the all-time high TTM cash from operations for Legend Biotech Corporation?
  • What is Legend Biotech Corporation TTM cash from operations year-on-year change?

What is Legend Biotech Corporation annual cash from operations?

The current annual cash from operations of LEGN is -$141.35M

What is the all-time high annual cash from operations for Legend Biotech Corporation?

Legend Biotech Corporation all-time high annual cash from operations is $307.68M

What is Legend Biotech Corporation annual cash from operations year-on-year change?

Over the past year, LEGN annual cash from operations has changed by +$243.11M (+63.23%)

What is Legend Biotech Corporation quarterly cash from operations?

The current quarterly cash from operations of LEGN is $28.91M

What is the all-time high quarterly cash from operations for Legend Biotech Corporation?

Legend Biotech Corporation all-time high quarterly cash from operations is $28.91M

What is Legend Biotech Corporation quarterly cash from operations year-on-year change?

Over the past year, LEGN quarterly cash from operations has changed by +$103.97M (+138.53%)

What is Legend Biotech Corporation TTM cash from operations?

The current TTM cash from operations of LEGN is -$170.25M

What is the all-time high TTM cash from operations for Legend Biotech Corporation?

Legend Biotech Corporation all-time high TTM cash from operations is -$4.26M

What is Legend Biotech Corporation TTM cash from operations year-on-year change?

Over the past year, LEGN TTM cash from operations has changed by -$17.75M (-11.64%)
On this page